I would like to point out one thing. The extraction of CBD is not as simple as it seems, and its application can be made difficult by its instability. It is also to give credibility to our industry that we are developing analytical methods adapted to the different can- nabinoid profiles of interest. These methods are based on UPLC techniques coupled with mass spectrometry. They allow us to ra- pidly validate our tests. L’UIVEC a pour vocation de développer et Actif’s Mag:Beyond these technological issues of extraction d’encadrer le marché des extraits de chanvre and analysis, are you involved in more fundamental en France. Regroupant différents acteurs research on the effects and mechanisms of action of économiques et industriels intéressés par cannabinoids? l’exploitation des extraits de chanvre (CBD, CBG, Olivier Maubert: R&D is essential for any young market. There CBN, etc., à l’exception du THC, du THC-A et are few credible scientific articles describing in a rigorous way the de tout autre stupéfiant), elle représente toute effects and especially the mechanisms of action of CBD and other la chaîne de valeur de la filière des extraits de cannabinoids, unlike THC which seems to interest the pharma- chanvre, de la production à la distribution en ceutical industry and for which research is progressing. passant par la transformation et le conseil. This is one of the subjects we are working on internally, but also Plusieurs adhérents sont issus de la nutraceutique through partnerships with a number of research centers. In (PiLeJe, Ineldea, laboratoires Gilbert, Epycure), de Greece, for example, we are collaborating with the University of l’agro-alimentaire (Rainbow Breen Future, Solinest), Athens on pharmacology issues. With the University of Oregon, des ingrédients (Spectrums Europe, Robertet), de which has a research department specializing in hemp agronomy, la prestation de service industriel (Irati, Strapharm), we are conducting joint work. du conseil (Nutrikeo). Des organisations The strategy that we have put in place at the R&D level aims to professionnelles y sont également présentes enable us to develop proprietary hemp extracts supported by (Synadiet, Facophar Santé, Cosmed). Et pour les clinical trials. Our expertise in the extraction of natural substances media, Actif’s Magazine… will enable us to offer these same grades in an eco-responsible manner through the implementation of our own production processes. By mobilizing a maximum of internal and external resources and UIVEC’s mission is to develop and supervise the by relying on our know-how, we are able to offer extracts that are hemp extract market in France. Bringing together safe for consumption. This is the added value that Robertet also different economic and industrial actors interested provides... • in the exploitation of hemp extracts (CBD, CBG, CBN, etc., except THC, THC-A and any other Olivier Maubert’s comments were collected in June 2021, before the narcotic), it represents the entire value chain of notification to the European Commission of the French cannabis the hemp extracts industry, from production to decree (July 20). distribution through processing and consulting. Comments collected by Philippe Millet Several members are from the nutraceutical industry (PiLeJe, Ineldea, Laboratoires Gilbert, Epycure), the food industry (Rainbow Breen Future, Solinest), ingredients (Spectrums Europe, Robertet), industrial services (Irati, Strapharm), and consulting 700 M€ (Nutrikeo). Professional organizations are also present (Synadiet, Facophar Santé, Cosmed). And for the media, Actif’s Magazine... for products containing CBD from the 1st year if favorable regulatory developments. in France. 53%7 billion € market share of food supplements with CBD versus other in 2025 in the United States. product categories in Europe. €14.7 billion1,16 billion € wordlwide in 2026 (€1.3 billion in 2018). in 2025 in the United Kingdom. #76 UIVEC en bref - UIVEC in short - 18 -GAM s’fitcA